✦ LIBER ✦

Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus

✍ Scribed by Tseng, Chin-Hsiao

Book ID: 126552412
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 604 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2014.08.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metformin may reduce bladder cancer risk

Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes

✍ Tseng, Chin Hsiao (author) 📂 Article 📅 2014 🏛 Springer-Verlag Italia s.r.l. 🌐 English ⚖ 208 KB

Metformin may reduce bladder cancer risk

Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes

✍ Tseng, Chin Hsiao (author) 📂 Article 📅 2014 🏛 Springer-Verlag Italia s.r.l. 🌐 English ⚖ 208 KB

Metformin may reduce breast cancer risk

Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes

✍ Tseng, Chin-Hsiao 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 160 KB

Metformin is associated with reduced ris

Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis

✍ Wang, Zheng; Lai, Song-tao; Xie, Li; Zhao, Jian-dong; Ma, Ning-yi; Zhu, Ji; Ren, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 819 KB

Metformin-inclusive sulfonylurea therapy

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort

✍ Mark L. Wahlqvist; Meei-Shyuan Lee; Chih-Cheng Hsu; Shao-Yuan Chuang; Jiunn-Tay 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Metformin-inclusive sulfonylurea therapy

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort

✍ Mark L. Wahlqvist; Meei-Shyuan Lee; Chih-Cheng Hsu; Shao-Yuan Chuang; Jiunn-Tay 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Objectives Type 2 diabetes (T2DM) may increase the risk of Parkinson's disease (PD). We evaluated the role of oral anti-hyperglycemic agents (OAA) in any diabetes–PD linkage. Methods From the Taiwan National Health Insurance database on 01-01-2000, a representative cohort of 800,000 was obtained be